title: The future of glioma treatment: stem cells, nanotechnology and personalized medicine.
abstract: The development of novel therapies, imaging techniques and insights into the processes that drive growth of CNS tumors have allowed growing enthusiasm for the treatment of CNS malignancies. Despite this energized effort to investigate and treat brain cancer, clinical outcomes for most patients continue to be dismal. Recognition of diverse tumor subtypes, behaviors and outcomes has led to an interest in personalized medicine for the treatment of brain tumors. This new paradigm requires evaluation of the tumor phenotype at the time of diagnosis so that therapy can be specifically tailored to each individual patient. Investigating novel therapies involving stem cells, nanotechnology and molecular medicine will allow diversity of therapeutic options for patients with brain cancer. These exciting new therapeutic strategies for brain tumors are reviewed in this article.
authors.affiliation: Department of Neurosurgery, University of Florida, Box 100265, Gainesville, FL 32610, USA. maryam.rahman@neurosurgery.ufl.edu
authors.forename: Maryam
authors.initials: M
authors.lastname: Rahman
authors.forename: Brian
authors.initials: B
authors.lastname: Hoh
authors.forename: Nathan
authors.initials: N
authors.lastname: Kohler
authors.forename: Erin M
authors.initials: EM
authors.lastname: Dunbar
authors.forename: Gregory J A
authors.initials: GJ
authors.lastname: Murad
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D014408:Biomarkers, Tumor / Q000378:metabolism; D001812:Blood-Brain Barrier / Q000378:metabolism; D016543:Central Nervous System Neoplasms / Q000473:pathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D019008:Drug Resistance, Neoplasm; D005910:Glioma / Q000473:pathology / Q000628:therapy*; D006801:Humans; D036103:Nanotechnology; D057285:Precision Medicine; D033581:Stem Cell Transplantation
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor